Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/23/2003CA2481349A1 Peptides for detection of antibody to a. phagocytophilum
10/23/2003CA2481328A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003CA2481239A1 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/23/2003CA2481186A1 Attenuated gram negative bacteria
10/23/2003CA2481087A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003CA2481042A1 Mycoplasma polypeptides
10/23/2003CA2480883A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003CA2480858A1 Treatment of gastroparesis
10/23/2003CA2480745A1 Methods for treating tweak-related conditions
10/23/2003CA2480217A1 G-type peptides to ameliorate atherosclerosis
10/23/2003CA2480176A1 Use of interleukin-24 to treat ovarian cancer
10/23/2003CA2480079A1 Antiangiogenic active immunotherapy
10/23/2003CA2479835A1 An ephrin-b receptor protein involved in carcinoma
10/22/2003EP1355158A1 Method for diagnosing inflammatory and infectious diseases by detecting the phosphoprotein LASP-1 as inflammation marker
10/22/2003EP1355156A2 A human endothelin receptor
10/22/2003EP1355152A1 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen
10/22/2003EP1355025A2 Anti-panic opening system for doors
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354952A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354951A1 Method of examining ability to control nerve cell plasticity
10/22/2003EP1354950A1 Nf-kb activating gene
10/22/2003EP1354949A1 Human fgf23 protein mutant lowering blood phosphorus level
10/22/2003EP1354948A1 Novel cancer-associated genes
10/22/2003EP1354947A1 Novel polypeptide
10/22/2003EP1354946A1 Bhlh-pas proteins, genes thereof and utilization of the same
10/22/2003EP1354895A1 Neopeptides useful for detection and treatment of cancer
10/22/2003EP1354894A2 Fusion peptide of human type-1 collagen derived peptide and tat peptide, preparation thereof, and skin anti-aging cosmetic composition comprising the same
10/22/2003EP1354893A2 Physiologically active complex
10/22/2003EP1354892A1 Peptides capable of inducing attraction of the axonal growth and their use for treating neurodegenerative diseases
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354890A1 Novel polypeptide and dna thereof
10/22/2003EP1354889A1 Trasncription activation complex and utilization thereof
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354204A2 Hcv antigen/antibody combination assay
10/22/2003EP1354199A2 Diagnosis and treatment of multiple sclerosis
10/22/2003EP1354196A2 Diagnostics, drug screening and treatment for cancer
10/22/2003EP1354061A2 Novel prkag3 alleles and use of the same as genetic markers for reproductive and meat quality traits
10/22/2003EP1354058A1 Isolation and characterisation of an anther-specific promoter (cofs) in cotton
10/22/2003EP1354056A2 Enhanced secretion of a polypeptide by a microorganism
10/22/2003EP1354045A2 Hyperglycosylated polypeptides
10/22/2003EP1354044A1 Nurr1 transcription factor i-box mutants having monomeric transcriptional activation activity
10/22/2003EP1354043A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1354041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/22/2003EP1354040A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/22/2003EP1354039A2 Atp-binding cassette transporter-like molecules and uses thereof
10/22/2003EP1354034A2 Transgenic transchromosomal rodents for making human antibodies
10/22/2003EP1354033A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
10/22/2003EP1354032A2 Gene regulation therapy involving ferritin
10/22/2003EP1354029A2 Foggy
10/22/2003EP1353954A2 Anticoagulants and their uses
10/22/2003EP1353953A2 Mu-1, member of the cytokine receptor family
10/22/2003EP1353952A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
10/22/2003EP1353951A1 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
10/22/2003EP1353950A2 Method and apparatus for the production of antigens and uses thereof
10/22/2003EP1353949A2 Compositions and methods relating to ovary specific genes and proteins
10/22/2003EP1353948A2 Soluble cyclic analogues of the beta amyloide peptide
10/22/2003EP1353946A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
10/22/2003EP1353945A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/22/2003EP1353943A1 NOVEL GENE ENCODING AN F-BOX PROTEIN WHICH REGULATES LEAF LONGEVITY IN i ARABIDOPSIS THALIANA /i AND MUTANT GENE THEREOF
10/22/2003EP1353942A2 Peptide inhibitors of hiv entry
10/22/2003EP1353941A2 Modified zinc finger binding proteins
10/22/2003EP1353940A2 Methods for producing and improving therapeutic potency of binding polypeptides
10/22/2003EP1353937A2 Specific human antibodies for selective cancer therapy
10/22/2003EP1353698A1 Recombinant serum albumin for use in cleansing or dermatological products for skin or hair
10/22/2003EP1353697A1 Method of preparing biological materials and preparation produced using same
10/22/2003EP1353691A2 Molecular antigen array presenting amyloid beta
10/22/2003EP1353689A2 Immunizing compositions and methods of use
10/22/2003EP1353688A2 Method and compositions for immunization with the pseudomonas v antigen
10/22/2003EP1353687A2 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
10/22/2003EP1353686A2 Mhc class i associated peptides for prevention and treatment of tuberculosis
10/22/2003EP1353683A2 Ghrelin analogs
10/22/2003EP1353680A2 Use of slpi for treating chronic inflammatory intestinal diseases
10/22/2003EP1353555A2 Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents
10/22/2003EP1353549A2 Mice heterozygous for wfs1 gene as mouse models for depression
10/22/2003EP1181371B1 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use
10/22/2003EP1180121B1 Long lasting insulinotropic peptides
10/22/2003EP1003872B1 Increasing production of proteins in gram-positive microorganisms
10/22/2003EP1003860B1 Modified dorsal tissue affecting factor and compositions
10/22/2003EP0986572B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
10/22/2003EP0922059B1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
10/22/2003EP0852620B1 Human jtv1 gene overlaps pms2 gene
10/22/2003EP0851927B1 Compounds for immunotherapy and diagnosis of tuberculosis
10/22/2003EP0815221B1 A novel growth factor and a genetic sequence encoding same
10/22/2003EP0659217B1 CLONING AND EXPRESSION OF beta APP-C100 RECEPTOR
10/22/2003CN1451058A Continuous electrolytic pickling method for metallic products using alternate current suplied cells
10/22/2003CN1451048A Expression of biologically active polypeptides in duckweed
10/22/2003CN1451047A Corynebacterium glutamicum genes encoding stress resistance and tolerance proteins
10/22/2003CN1451046A 保守的奈瑟球菌抗原 Conservative Neisseria antigen
10/22/2003CN1451045A IFN-alpha homologues
10/22/2003CN1451044A Neutrokine－α和Neutrokine－α剪接变体 Neutrokine-α and Neutrokine-α splice variants
10/22/2003CN1451040A Method for preparing human thrombopoietin polytides by mammalian cell cultures
10/22/2003CN1451038A Attenuated influenza virus useful as vaccine
10/22/2003CN1451017A Selective cyclic peptides
10/22/2003CN1451016A Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method
10/22/2003CN1451015A Insect poison allergens with reduced LgE reactivity and method for producing the same
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/22/2003CN1450910A Mutant simplex virus for treating hyperproliferative cell growth
10/22/2003CN1450909A Monoclonal antibodies and antibody cocktail for detection of prion protein as an indiction of transmissible spongiform encephalopathies
1 ... 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 ... 2916